How well data and research are integrated into a presentation or pitch can make or break it. But not every marketer is a natural-born data geek. How can you work staid data points into a compelling ...

Key data being presented at EHA 2025 include: An oral presentation reporting updated results from the Phase 1 BEAT AML trial evaluating the combination of revumenib with venetoclax and azacitidine ...

Incyte Corporation (NASDAQ:INCY) saw its stock surge 7% after the company announced that multiple research presentations, ...

According to a new study in the Journal of Consumer Research, data presented in ... might want to use frequency format for sequential data presentation, since consumer judgment updating seems ...

The TEASE-2 trial is an ongoing, fully enrolled, randomized, double-masked, placebo-controlled trial in 80 patients with moderate Stargardt disease, expected to read out topline data in 2025.

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE ... for Treatment and Research in Multiple Sclerosis ...

as late-breaking data presentations at SLEEP 2024, the 38 th annual meeting of the American Academy of Sleep Medicine and the Sleep Research Society. TAK-861 is an investigational oral orexin ...

Cagnoni, M.D., President and Head of Research and Development ... including statements regarding the presentation of data from Incyte’s clinical development pipeline, the promise presented ...

CHAPTER 3 has been written! Sans errors in terminology, syntax, tenses and spelling, you have successfully described how you went through conducting your research. Standard English has become a part ...

Key data being presented at EHA 2025 include: The accepted abstracts listed below are now available online at the EHA conference website. Copies of the oral and poster presentations will be made ...